The Evolution of Axillary Surgery in Breast Cancer-Towards De-escalation.
作者信息
Papila Berrin
机构信息
Department of General Surgery, İstanbul University Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.
出版信息
Balkan Med J. 2025 May 5;42(3):183-184. doi: 10.4274/balkanmedj.galenos.2025.2025.160425.
Abstract
摘要
相似文献
1
The Evolution of Axillary Surgery in Breast Cancer-Towards De-escalation.
Balkan Med J. 2025 May 5;42(3):183-184. doi: 10.4274/balkanmedj.galenos.2025.2025.160425.
2
De-escalating Surgery Among Patients with HER2 + and Triple Negative Breast Cancer.
Curr Breast Cancer Rep. 2022;14(4):135-141. doi: 10.1007/s12609-022-00453-3. Epub 2022 Jul 27.
3
Axillary surgery in oncologic breast surgery: a narrative review.
Gland Surg. 2023 Dec 26;12(12):1774-1785. doi: 10.21037/gs-23-362. Epub 2023 Dec 22.
4
Real de-escalation or escalation in disguise?
Breast. 2023 Jun;69:249-257. doi: 10.1016/j.breast.2023.03.001. Epub 2023 Mar 4.
5
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
Ann Surg Oncol. 2025 May;32(5):3278-3291. doi: 10.1245/s10434-025-16973-y. Epub 2025 Feb 13.
6
Optimizing Axillary Management in Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy.
Clin Breast Cancer. 2025 Aug;25(6):521-528.e1. doi: 10.1016/j.clbc.2025.03.020. Epub 2025 Mar 31.
7
De-escalation of axillary treatment in early breast cancer-a narrative review of current trials.
Transl Breast Cancer Res. 2025 Jan 21;6:5. doi: 10.21037/tbcr-24-45. eCollection 2025.
8
De-escalation of axillary irradiation for early breast cancer - Has the time come?
Cancer Treat Rev. 2021 Dec;101:102297. doi: 10.1016/j.ctrv.2021.102297. Epub 2021 Oct 8.
9
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
Breast Care (Basel). 2021 Dec;16(6):584-589. doi: 10.1159/000518376. Epub 2021 Aug 17.
10
De-escalation of Axillary Surgery After Neoadjuvant Therapy.
Clin Breast Cancer. 2024 Jul;24(5):385-391. doi: 10.1016/j.clbc.2024.04.009. Epub 2024 Apr 20.
本文引用的文献
1
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update.
J Clin Oncol. 2025 May 10;43(14):1720-1741. doi: 10.1200/JCO-25-00099. Epub 2025 Apr 10.
2
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.
N Engl J Med. 2025 Mar 13;392(11):1051-1064. doi: 10.1056/NEJMoa2412063. Epub 2024 Dec 12.
3
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.
J Clin Oncol. 2025 Mar;43(7):810-820. doi: 10.1200/JCO.24.01052. Epub 2024 Nov 7.
4
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2024 Jul;22(5):331-357. doi: 10.6004/jnccn.2024.0035.
5
Axillary Surgery for Breast Cancer in 2024.
Cancers (Basel). 2024 Apr 23;16(9):1623. doi: 10.3390/cancers16091623.
6
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759.
7
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
J Natl Compr Canc Netw. 2023 Jun;21(6):594-608. doi: 10.6004/jnccn.2023.0031.
8
Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
Ann Surg Oncol. 2022 Oct;29(10):6133-6139. doi: 10.1245/s10434-022-12240-6. Epub 2022 Jul 28.
9
De-escalating axillary surgery in early-stage breast cancer.
Breast. 2022 Mar;62 Suppl 1(Suppl 1):S43-S49. doi: 10.1016/j.breast.2021.11.018. Epub 2021 Dec 15.
10
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study.
Eur J Surg Oncol. 2021 Oct;47(10):2506-2514. doi: 10.1016/j.ejso.2021.06.024. Epub 2021 Jun 24.
Zotero 插件